We are not a beauty clinic, nor are we cosmetic surgeons.
As an Accredited Healthcare Facility (1), epiclinic performs Cosmetic Medicine with the priority to put patients’ well-being first, not only in patient safety, but also by seeking out evidence-based procedures researched from the medical literature (2), and demonstrating effectiveness. In medical terms, this is called ‘efficacy’. Efficacy is not a one-size-fits-all, which is why we take the time to listen to patients expectations and to provide constructive feedback about potential choices of treatment.
A strong advocate in providing patients with quality Cosmetic Medical procedures, our charter is ‘to look better, not different’. We take time to help patients understand the procedures we perform in plain language and plenty of opportunity to ask questions or seek clarification about outcomes.
It is important that patients have adequate and comprehensive information because Cosmetic Medicine is real medicine, often using doctor-prescribed real prescription-only medications such as anti-wrinkle injections. And don’t forget that dermal fillers are not only real prescription-only medications, they are also classified as medical devices too. Just like any medication prescribed by doctors, there can be risks involved for some patients undergoing cosmetic medical procedures. These risks can vary from patient-to-patient, in variation of procedure techniques and in the substances and devices themselves.
The same principles that apply to prescription-only medications, also apply just the same using medical devices such as medical lasers, radio-frequency (RF), cryolipolysis (Coolsculpting),ultrasound etc, for their various Cosmetic Medical purposes. For the right person, all of these devices can provide significant benefit. No Cosmetic Medical procedure is completely risk free, so it is very important to select procedures and techniques with patient safety as the primary objective.
Epiclinic has been performing Coolsculpting since it was introduced to Australia. Coolsculpting, developed by Harvard Medical School by USA company Zeltiq, reduces localised fat deposits using a technology called ‘cryolipolysis’. In plain language this means ‘to freeze fat cells (adipocytes) and dispose of the contents’. Of course, this does not mean all fat cells in the treated area, but a significant proportion. When fat cells are held at a constant low temperature, the fat cells enter a biological process known as ‘apoptosis’. Apoptosis is the natural ‘end of life’ signal to all human living cells (that contain the body’s DNA). We do not produce many, if any, new fat cells after puberty, so those cells treated by Coolsculpting are highly unlikely to be replaced. So if you maintain a healthy lifestyle, the effects of localised fat deposits is reduced over a long time. Coolsculpting is not a panacea for obesity, but is effective in most people to reduce stubborn areas of fatty deposits.
It is important for all patients to be appropriately assessed by trained and experienced personnel, as not all patients are suitable for this procedure. At epiclinic our Coolsculpting experience spans more than thirteen years, and we perform these procedures most days at our clinic in Wakefield Street. Following initial training, and as experiences developed, Epiclinic adopted advances in Coolsculpting technology, attending advanced training in Pleasanton, California USA February 13th 2015 and since that time, our personnel have trained other personnel and allied health workers in Coolsculpting in Australia (NSW), Indonesia (Jakarta) and Hong Kong .